Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine for distal intestinal inflammation in ulcerative colitis
IRCT201604307080N3Phase 3Completed
- Sponsor
- Vice Chancellor for research of Babol University of Medical Sciences
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Salcrozine in autoimmune colitis, sponsored by Vice Chancellor for research of Babol University of Medical Sciences. Started Dec 2014; status: completed.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on IRCT201604307080N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201604307080N3.